Neurocrine Biosciences
NBIX
#1222
Rank
C$21.81 B
Marketcap
$215.44
Share price
-0.46%
Change (1 day)
11.72%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): C$0.88 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are C$2.24 Billion. In 2023 the company made an earning of C$0.51 Billion, an increase over its 2022 earnings that were of C$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.88 B71.86%
2023 C$0.51 B62.85%
2022 C$0.31 B73.74%
2021 C$0.18 B-8.82%
2020 C$0.19 B77.78%
2019 C$0.11 B49.83%
2018 C$74.96 M-142.57%
2017 -C$0.18 Billion-14.73%
2016 -C$0.21 Billion53.15%
2015 -C$0.14 Billion46.25%
2014 -C$92.2 Million29.66%
2013 -C$71.11 Million-3530.8%
2012 C$2.07 M-95.73%
2011 C$48.55 M
2009 -C$68.26 Million-45.38%
2008 -C$0.13 Billion-58.87%
2007 -C$0.31 Billion87.3%
2006 -C$0.17 Billion351.97%
2005 -C$35.89 Million-52.09%
2004 -C$74.92 Million-10.98%
2003 -C$84.15 Million
2001 -C$62.82 Million
1999 -C$28.33 Million108.32%
1998 -C$13.6 Million
1996 C$4.15 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$27.51 M-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.74 B 192.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
-C$46.3 Million-104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.52 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.30 B 995.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.93 B 957.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$10.74 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$59.78 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA